NCBI National Center for Biotechnology Information |
Biological unit 1: | dimeric | ||
Source organism: | Homo sapiens | ||
Number of proteins: | 2 (Heat shock protein HSP 90-alpha ▼) Protein molecule
close
|
PDB ID | Description | Taxonomy | Aligned Protein | RMSD | Aligned Residues | Sequence Identity | |||
---|---|---|---|---|---|---|---|---|---|
1 | Full |
2BT0 | Novel, potent small molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design |
Homo sapiens |
2 | 0.54Å | 414 | 99% | |
2 | Full |
5FND | Dynamic Undocking and the Quasi-Bound State as tools for Drug Design |
Homo sapiens |
2 | 0.65Å | 414 | 99% | |
3 | Full |
2VCI | 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer |
Homo sapiens |
2 | 0.66Å | 414 | 99% | |
4 | Full |
2YE6 | HSP90 inhibitors and drugs from fragment and virtual screening |
Homo sapiens |
2 | 0.68Å | 414 | 99% | |
5 | Full |
2YE4 | HSP90 inhibitors and drugs from fragment and virtual screening |
Homo sapiens |
2 | 0.71Å | 414 | 99% | |
6 | Full |
2YI6 | Structural Characterization Of 5-Aryl-4-(5-Substituted-2- 4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors |
Homo sapiens |
2 | 0.77Å | 414 | 99% | |
7 | Full |
2YI7 | Structural Characterization Of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors |
Homo sapiens |
2 | 0.86Å | 414 | 99% | |
8 | Full |
2BSM | Novel, potent small molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design |
Homo sapiens |
2 | 0.86Å | 414 | 99% | |
9 | Full |
2YE5 | HSP90 inhibitors and drugs from fragment and virtual screening |
Homo sapiens |
2 | 0.87Å | 414 | 99% | |
10 | Full |
2YEB | HSP90 inhibitors and drugs from fragment and virtual screening |
Homo sapiens |
2 | 0.87Å | 414 | 99% |